Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Regulatory News:
Orexo (STO:ORX)
Unless otherwise stated in this report, all data refers to the Group. Figures in parentheses relate to the corresponding period in 2012.
The transition to a commercial and profitable pharmaceutical company continues
During the period
•Net revenues amounted to MSEK 139.8 (83.6).
Help employers find you! Check out all the jobs and post your resume.
